Germany ends statutory insurance coverage for cannabis flower

Move marks reversal of reimbursement access for medical cannabis patients in Europe's largest market.

FILE — statehouse · B.D. Gilfry / CC BY-SA 2.0

Germany has discontinued statutory insurance reimbursement for cannabis flower, according to MMJDaily. The decision represents a significant shift in patient access to medical cannabis in a market that imported 218 tons of legal cannabis in the prior year, per Cannabis Now reporting.

The move appears to conflict with other regulatory developments. Germany's drug commissioner backed cannabis pilot projects in June, and patient advocacy groups have since challenged the coverage cuts, as reported by Business of Cannabis in late July. The timing suggests ongoing tension between expansion-minded policymakers and cost-containment pressures within the statutory insurance system.

Watch whether patient legal challenges gain traction or whether alternative reimbursement pathways (private insurance, direct-pay models) emerge to sustain demand in a market where international operators like Organigram have identified Germany as a growth opportunity.